Wong AJ - Search Results

1

A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors.

Moscatello DK, Ramirez G, Wong AJ. Moscatello DK, et al. Among authors: wong aj. Cancer Res. 1997 Apr 15;57(8):1419-24. Cancer Res. 1997. PMID: 9108438

2

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.

Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ. Moscatello DK, et al. Among authors: wong aj. Cancer Res. 1995 Dec 1;55(23):5536-9. Cancer Res. 1995. PMID: 7585629

3

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR. Reist CJ, et al. Among authors: wong aj. Cancer Res. 1995 Oct 1;55(19):4375-82. Cancer Res. 1995. PMID: 7671250

4

Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.

Moscatello DK, Montgomery RB, Sundareshan P, McDanel H, Wong MY, Wong AJ. Moscatello DK, et al. Among authors: wong aj, wong my. Oncogene. 1996 Jul 4;13(1):85-96. Oncogene. 1996. PMID: 8700557

5

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor.

Moscatello DK, Holgado-Madruga M, Emlet DR, Montgomery RB, Wong AJ. Moscatello DK, et al. Among authors: wong aj. J Biol Chem. 1998 Jan 2;273(1):200-6. doi: 10.1074/jbc.273.1.200. J Biol Chem. 1998. PMID: 9417065 Free article.

6

Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor.

Antonyak MA, Moscatello DK, Wong AJ. Antonyak MA, et al. Among authors: wong aj. J Biol Chem. 1998 Jan 30;273(5):2817-22. doi: 10.1074/jbc.273.5.2817. J Biol Chem. 1998. PMID: 9446590 Free article.

7

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME. Tang CK, et al. Among authors: wong aj. Cancer Res. 2000 Jun 1;60(11):3081-7. Cancer Res. 2000. PMID: 10850460

8

Elevated JNK activation contributes to the pathogenesis of human brain tumors.

Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ. Antonyak MA, et al. Among authors: wong aj. Oncogene. 2002 Aug 1;21(33):5038-46. doi: 10.1038/sj.onc.1205593. Oncogene. 2002. PMID: 12140754

9

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.

Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S. Modjtahedi H, et al. Among authors: wong aj. Int J Cancer. 2003 Jun 10;105(2):273-80. doi: 10.1002/ijc.11055. Int J Cancer. 2003. PMID: 12673691

10

The molecular biology and molecular genetics of astrocytic neoplasms.

Wong AJ, Zoltick PW, Moscatello DK. Wong AJ, et al. Semin Oncol. 1994 Apr;21(2):139-48. Semin Oncol. 1994. PMID: 8153660 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters